[PERSON]
Tatiana Sampaio
Featured in 3 tracked stories · first seen
Situations
Anvisa restrictions on polylaminin use in Brazil
3 clusters · 14 sources · last updated
Latest: Hospital Regional de Barbacena conducts second polylaminin application
Brazil’s National Health Surveillance Agency (Anvisa) has implemented stricter regulations on the compassionate use of polylaminin, an experimental protein derived from human placenta intended for spinal cord injury rege
Also covered in
-
Cristália and UFRJ begin Phase 1 trials for polylaminin
[HEALTH] · 22 sources ·
-
Seven deaths linked to experimental polylaminina treatment in Brazil
[HEALTH] · 6 sources ·